---
title: "Cantor Fitzgerald Remains a Buy on 89bio (ETNB)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263776448.md"
description: "According to TipRanks, Seedhouse is a 4-star analyst with an average return of 11.5% and a 44.69% success rate. Seedhouse covers the Healthcare sector, focusing on stocks such as Astria Therapeutics, BioCryst, and Tvardi Therapeutics. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for 89bio with a $30.19 average price target."
datetime: "2025-10-31T14:57:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263776448.md)
  - [en](https://longbridge.com/en/news/263776448.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263776448.md)
---

# Cantor Fitzgerald Remains a Buy on 89bio (ETNB)

According to TipRanks, Seedhouse is a 4-star analyst with an average return of 11.5% and a 44.69% success rate. Seedhouse covers the Healthcare sector, focusing on stocks such as Astria Therapeutics, BioCryst, and Tvardi Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for 89bio with a $30.19 average price target.

### Related Stocks

- [ETNB.US](https://longbridge.com/en/quote/ETNB.US.md)